InnovAge Holding Corp. (NASDAQ:INNV) Q2 2024 Earnings Conference Call February 6, 2024 5:00 PM ET
Company Participants
Ryan Kubota - Director, IR
Patrick Blair - President and CEO
Benjamin Adams - CFO
Dr. Rich Pfeiffer - Chief Medical Officer
Conference Call Participants
Jason Cassorla - Citi
Jared Haase - William Blair
Jamie Perse - Goldman Sachs
Operator
Good day and thank you for standing by. Welcome to the InnovAge Second Quarter 2024 Earnings Conference Call.
At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator instructions] Please be advised that today's conference is being recorded.
I will now hand the conference over to your first speaker today, Ryan Kubota, Director of Investment Relations. Please go ahead.
Ryan Kubota
Thank you, operator. Good afternoon and thank you all for joining the InnovAge fiscal 2024 second quarter earnings call. With me today is Patrick Blair, President and CEO, and Ben Adams, CFO. Dr. Rich Pfeiffer, Chief Medical Officer, will also be joining the Q&A portion of the call.
Today, after the market closed, we issued a press release containing detailed information on our quarterly results for our fiscal second quarter 2024. You may access the release on our Investor Relations sections of our company website, innovate.com. For those listening to the rebroadcast of this call, we remind you that the remarks made herein are as of today, Tuesday, February 06, 2024, and have not been updated subsequent to this call.
During our call, we refer to certain non-GAAP measures. A reconciliation of these measures to the most directly comparable GAAP measures can be found in our earnings press release posted on our website. We will also be making forward-looking statements, including statements related to our full fiscal year projections, future growth prospects, Florida de novo centers, our acquisition of ConcertoCare, our payer capabilities and clinical value initiatives, the status of current and future regulatory actions, and other expectations. Listeners are cautioned that all of our forward-looking statements involve certain assumptions and are inherently subject to risk and uncertainties that can cause our actual results to differ materially from our current expectations. We advise listeners to review the risk factors discussed in our Form 10-K annual report for fiscal year 2023 and our subsequent reports filed with the SEC, including our most recent quarterly report on Form 10-Q. After the completion of our prepared remarks, we will open the call for questions.